Zhengying Pan

3.9k citations
42 papers · 3.0k indexed · 2 hit papers · h-index 21
Topics
Chronic Lymphocytic Leukemia Research (14 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Click Chemistry and Applications (6 papers)

In The Last Decade

Zhengying Pan

42 papers receiving 3.0k citations

Hit Papers

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-c...2006202620122019201020062505007501000

Peers

Zhengying Pan
Comparison fields: 5 of 107
  • Genetics 1.4k
  • Molecular Biology 1.3k
  • Pathology and Forensic Medicine 840
  • Oncology 702
  • Hematology 681
Replace Kumudha Balakrishnan with:
Kumudha Balakrishnan United States
Erik Verner United States
Mint Sirisawad United States
Kami J. Maddocks United States
Enrique M. Ocio Spain
Juerg Schwaller Switzerland
Markus Müschen United States
William C. Shakespeare United States
Stephen K. Tahir United States
Judy Lucas United States
Zhengying Pan relative to Kumudha Balakrishnan United States Kumudha Balakrishnan's profile →
Citations per field
00.5×
Kumudha Balakrishnan · 1×
Citations per year

Countries citing papers authored by Zhengying Pan

Since Specialization
Citations

This map shows the geographic impact of Zhengying Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengying Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengying Pan more than expected).

Fields of papers citing papers by Zhengying Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengying Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengying Pan. The network helps show where Zhengying Pan may publish in the future.

Co-authorship network of co-authors of Zhengying Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengying Pan. A scholar is included among the top collaborators of Zhengying Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengying Pan. Zhengying Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 10
4 7
5 1
6 4
7 23
8 8
9 263
10 43
11 5
12 27
13 8
14 66
15 41
16 21
17 54
18
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinasebreakdown →
517
19 25
20 131

About Zhengying Pan

Zhengying Pan is a scholar working on Genetics, Oncology and Organic Chemistry, having authored 42 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Click Chemistry and Applications (6 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (681 citations) and Pathology and Forensic Medicine (840 citations). Zhengying Pan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lee Honigberg, Richard A. Miller, Joseph J. Buggy, Betty Chang, Douglas H. Thamm, Ashley M. Smith, Mint Sirisawad, Erik Verner, David Loury and Gang Xue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026